Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reproxalap in seasonal allergic conjunctivitis (EEC)
NCT03709121Phase 2Completed
- Sponsor
- Aldeyra Therapeutics
- Start
- Oct 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of reproxalap in seasonal allergic conjunctivitis (SAC), sponsored by Aldeyra Therapeutics. Started Oct 2018; status: completed.
02
Drugs
reproxalap
03
Conditions
seasonal allergic conjunctivitis (SAC)
Beyond the preview
Go deeper on NCT03709121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03709121.